Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.

PubMed  Google Scholar 

Sanchón R, Gambineri A, Alpañés M, Martínez-García MÁ, Pasquali R, Escobar-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod. 2012;27:1209–16.

Article  PubMed  Google Scholar 

Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–73.

Article  PubMed  Google Scholar 

Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95:2038–49.

Article  CAS  PubMed  Google Scholar 

Dolian GG, Burnazian RA, Vanetsian AL, Okoev GG, Abgarian MT (1989) Diagnostic criteria for polycystic ovary syndrome. Akush Ginekol (Mosk) 26–28

Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19:41–47

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.

Article  CAS  PubMed  Google Scholar 

Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69–82.

Article  PubMed  Google Scholar 

Heptulla RA, Stewart A, Enocksson S, Rife F, Ma TY-Z, Sherwin RS, Tamborlane WV, Caprio S. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study. Pediatr Res. 2003;53:830–5.

Article  CAS  PubMed  Google Scholar 

Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. J Clin Endocrinol Metab. 2003;88:1503–11.

Article  CAS  PubMed  Google Scholar 

Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, Clement TW, Eckel RH, Perreault L, Rewers M. The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab. 2013;98:E40–50.

Article  CAS  PubMed  Google Scholar 

Moon H-S, Dalamaga M, Kim S-Y, Polyzos SA, Hamnvik O-P, Magkos F, Paruthi J, Mantzoros CS. Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev. 2013;34:377–412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update. 2012;18:568–85.

Article  CAS  PubMed  Google Scholar 

Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, García-Robles R. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2000;85:4182–7.

CAS  PubMed  Google Scholar 

Roldán B, Escobar-Morreale HF, Barrio R, de La Calle H, Alonso M, García-Robles R, Sancho J. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care. 2001;24:1297–9.

Article  PubMed  Google Scholar 

Cho YH, Craig ME, Donaghue KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15:18–26.

Article  CAS  PubMed  Google Scholar 

Łebkowska A, Adamska A, Krentowska A, Uruska A, Rogowicz-Frontczak A, Araszkiewicz A, Ożegowska K, Hryniewicka J, Leśniewska M, Wender-Ożegowska E, et al. The influence of prepubertal onset of type 1 diabetes and age of menarche on polycystic ovary syndrome diagnosis. J Clin Endocrinol Metab. 2021;106:1811–20.

Article  PubMed  Google Scholar 

Escobar-Morreale HF, Roldán-Martín MB. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care. 2016;39:639–48.

Article  CAS  PubMed  Google Scholar 

Smith GD, Ebrahim S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.

Article  PubMed  Google Scholar 

Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.

Article  PubMed  PubMed Central  Google Scholar 

Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14:e1007813.

Article  PubMed  PubMed Central  Google Scholar 

Chaudhary H, Patel J, Jain NK, Joshi R. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14:125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Onengut-Gumuscu S, Webb-Robertson B-JM, Sarkar S, Manichaikul A, Hu X, Frazer-Abel A, Holers VM, Rewers MJ, Rich SS. Genetic variants in the complement system and their potential link in the aetiology of type 1 diabetes. Diabetes/Metabolism Research and Reviews, 2023; e3716.

Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care. 2008;31:1546–9.

Article  PubMed  PubMed Central  Google Scholar 

Zhu M, Xu K, Chen Y, Gu Y, Zhang M, Luo F, Liu Y, Gu W, Hu J, Xu H, et al. Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals: based on a two-stage genome-wide association study. Diabetes Care. 2019;42:1414–21.

Article  CAS  PubMed  Google Scholar 

Branavan U, Muneeswaran K, Wijesundera S, Jayakody S, Chandrasekharan V, Wijeyaratne C. Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques. PLOS ONE. 2018;13:e0209830.

Article  PubMed  PubMed Central  Google Scholar 

Hu K-L, Zhao H, Min Z, He Y, Li T, Zhen X, Ren Y, Chang H-M, Yu Y, Li R. Increased expression of KISS1 and KISS1 receptor in human granulosa lutein cells-potential pathogenesis of polycystic ovary syndrome. Reprod Sci. 2019;26:1429–38.

Article  CAS  PubMed  Google Scholar 

Amin M, Horst N, Wu R, Gragnoli C. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome. J Ovarian Res. 2023;16:155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amin M, Horst N, Gragnoli C. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome. J Ovarian Res. 2023;16:158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bayona A, Martínez-Vaello V, Zamora J, Nattero-Chávez L, Luque-Ramírez M, Escobar-Morreale HF. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Hum Reprod Update. 2022;28:501–17.

Article  CAS  PubMed  Google Scholar 

Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O’Reilly MW, Arlt W, Moore K, et al. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Hum Reprod. 2018;33:1727–34.

Article  CAS  PubMed  Google Scholar 

Amato MC, Guarnotta V, Ciresi A, Modica R, Pantò F, Giordano C. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2014;99:203–11.

Article  CAS  PubMed  Google Scholar 

Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, Evans DM, Smith GD. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4:330–45.

Article  PubMed  PubMed Central  Google Scholar 

Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, Beran D. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64:2741–50.

Article  PubMed  PubMed Central  Google Scholar 

Harding JL, Wander PL, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram RA, Magliano DJ, et al. The incidence of adult-onset Type 1 diabetes: a systematic review from 32 countries and regions. Diabetes Care. 2022;45:994–1006.

Article  PubMed  PubMed Central  Google Scholar 

Carmina E, Lobo RA. Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome? J Womens Health. 2018;27:1385–8.

Article  Google Scholar